BranchLab, a New York-based data science company developing advanced AI software that enables healthcare brands to reach the right consumers, closed a seed funding round.
Investors
The round was led by Newark venture partners (nvp), with participation from Aperiam and several other strategic investors.
Founded in 2015, newark venture partners (nvp) is a seed-stage, globally investing venture capital firm that backs bold founders building the next generation of enterprise software.
BranchLab Use of Funds
The company will use the funding to accelerate product development and market expansion for its privacy-safe healthcare advertising solutions for TV.
About BranchLab
Founded by Josh Walsh, Michael Parkes, and Chris Cagle, BranchLab provides a new solution for healthcare and pharma brands to reach consumers in a privacy-compliant way. Its database, HealthGraph™, aggregates anonymized data from over 300 million US residents and their healthcare journeys, including data on 2.1 million healthcare providers. BranchLab operates in the U.S. and is based in New York with offices in Colorado and Pennsylvania.
Funding Details
Company: BranchLab, Inc.
Raised: Undisclosed
Round: Seed Round
Funding Month: June 2024
Lead Investors: newark venture partners
Additional Investors: Aperiam
Company Website: https://branchlab.com/
Software Category: Data Solutions
Source: https://www.businesswire.com/news/home/20240606132070/en/